C301-9090 Screening compound: 3,4,5-trimethoxy-N-{5-[(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)sulfanyl]-1,3,4-thiadiazol-2-yl}benzamide

C301-9090 Screening compound: 3,4,5-trimethoxy-N-{5-[(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)sulfanyl]-1,3,4-thiadiazol-2-yl}benzamide
C301-9090 Screening compound: 3,4,5-trimethoxy-N-{5-[(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)sulfanyl]-1,3,4-thiadiazol-2-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C301-9090
3,4,5-trimethoxy-N-{5-[(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)sulfanyl]-1,3,4-thiadiazol-2-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C301-9090

Molecular Formula

C20H21N7O6S2 (C20 H21 N7 O6 S2)

Compound Name

3,4,5-trimethoxy-N-{5-[(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)sulfanyl]-1,3,4-thiadiazol-2-yl}benzamide

IUPAC name

345-trimethoxy-N-{5-[(137-trimethyl-26-dioxo-2367-tetrahydro-1H-purin-8-yl)sulfanyl]-134-thiadiazol-2-yl}benzamide

SMILES

Cn1c(Sc2nnc(NC(c(cc3OC)cc(OC)c3OC)=O)s2)nc(N(C)C(N2C)=O)c1C2=O

InChI

InChI=1S/C20H21N7O6S2/c1-25-12-14(26(2)20(30)27(3)16(12)29)21-18(25)35-19-24-23-17(34-19)22-15(28)9-7-10(31-4)13(33-6)11(8-9)32-5/h7-8H,1-6H3,(H,22,23,28)

InChI Key

RFOCXPHDZYVBCO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14745795

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

519.56

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

13

Partition Coefficient, logP

2.975

Distribution Coefficient, logD

2.974

Water Solubility, LogSw

-3.43

Polar Surface Area

113.071

Acid Dissociation Constant (pKa)

9.90

Base Dissociation Constant (pKb)

3.17

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

C301-9090 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

C-Met Library (15277 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
Targets:
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C301-9090 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C301-9090?
Check Price and Availability of C301-9090, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C301-9090 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C301-9090
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C301-9090
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C301-9090 available by request